PATTERNS OF CARE AND CLINICAL OUTCOMES WITH CYTARABINE-ANTHRACYCLINE INDUCTION CHEMOTHERAPY FOR AML PATIENTS IN THE US

EHA Library, Jan Philipp Bewersdorf, 294471

LONG-TERM FOLLOW-UP OF A PHASE 1/2 STUDY OF VENETOCLAX PLUS LOW-DOSE CYTARABINE IN PREVIOUSLY UNTREATED OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Andrew Wei, 294472

FLUGAZA TRIAL: A PHASE III RANDOMIZED, OPEN LABEL STUDY COMPARING AZACITIDINE VERSUS FLUDARABINE AND CYTARABINE (FLUGA SCHEME) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Susana Vives Polo, 294473

FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA

EHA Library, Jeffrey Lancet, 294474

PRELIMINARY RESULTS OF A PHASE I/II STUDY OF AZACITIDINE, VENETOCLAX AND PEVONEDISTAT IN PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY

EHA Library, Nicholas Short, 294475

HLA-HAPLOIDENTICAL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY ERADICATES ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS

EHA Library, Antonio Pierini, 294476

OVERALL SURVIVAL (OS) AND QUALITY OF LIFE (QOL) OF OLDER ADULTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) AND TREATED UNDER CONDITIONS OF USUAL CLINICAL PRACTICE: INTERIM REPORT OF THE SVLMA STUDY

EHA Library, Fernando Ramos, 294477

VALIDATION OF THE EUROPEAN LEUKEMIANET 2017 AML PROGNOSTIC CLASSIFICATION FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN A RISK-ADAPTED TREATMENT PROTOCOL (CETLAM 2012)

EHA Library, Alex Bataller, 294478

ESCALATED DOSING SCHEDULES OF CC-486 ARE EFFECTIVE AND WELL TOLERATED FOR PATIENTS EXPERIENCING FIRST ACUTE MYELOID LEUKEMIA (AML) RELAPSE: RESULTS FROM THE PHASE III QUAZAR AML-001 MAINTENANCE TRIAL

EHA Library, Hartmut Döhner, 294479

OUTCOMES IN OLDER PATIENTS WITH HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA WHO ACHIEVED REMISSION WITH CPX-351 VERSUS 7+3 BUT DID NOT UNDERGO TRANSPLANT: PHASE 3 EXPLORATORY ANALYSIS

EHA Library, Tara L. Lin, 294480

IBRUTINIB ADDED TO 10-DAY DECITABINE FOR OLDER PATIENTS WITH AML AND HIGH-RISK MDS

EHA Library, Gerwin Huls, 294481

APPLICATION AND CLINICAL STUDY OF CLONAL HETEROGENEITY ANALYSIS IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiaodong Lyu, 294482

PROGNOSTIC IMPACT OF TIME FROM DIAGNOSIS TO INITIAL TREATMENT FOR ACUTE MYELOID LEUKEMIA

EHA Library, Yoshimasa Kamoda, 294483

STANDARDIZED IDENTIFICATION OF MEASURABLE RESIDUAL DISEASE (MRD) BY MULTICOLOR FLOW CYTOMETRY (MFC) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Maximilian Roehnert, 294484

THE RELATIONSHIP BETWEEN PATIENT-REPORTED OUTCOMES AND CLINICAL OUTCOMES IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: RESULTS FROM THE PHASE 3 ADMIRAL STUDY

EHA Library, David Cella, 294485

PHASE 3 STUDY ASSESSING THE SAFETY AND EFFICACY OF MIDOSTAURIN IN YOUNGER AND OLDER PATIENTS WITH NEWLY DIAGNOSED, FLT3-MUTATED ACUTE MYELOID LEUKEMIA WHO ARE ELIGIBLE FOR 7+3 OR 5+2 CHEMOTHERAPY

EHA Library, Jorge Sierra, 294486

CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ARSENIC TRIOXIDE - AN INTERNATIONAL COLLABORATIVE STUDY

EHA Library, Sabine Kayser, 294487

EVOLVING TREATMENT PATTERNS AND OUTCOMES OF 3637 ≥60 YEAR-OLD PATIENTS WITH NEWLY DIAGNOSED AML REPORTED TO THE PETHEMA EPIDEMIOLOGIC REGISTRY.

EHA Library, Evelyn Acuna, 294488

EXPLORATORY ANALYSIS OF THE EFFICACY AND SAFETY OF CPX-351 VERSUS 7+3 BY EUROPEAN LEUKEMIANET (ELN) 2017 RISK GROUPS IN A PHASE 3 STUDY OF OLDER ADULTS WITH HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA

EHA Library, Thomas Prebet, 294489

CHANGES IN THE APPROACH TO CARE AND IN TREATMENT OUTCOMES IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS IN THE ERA OF VENETOCLAX BASED REGIMENS: A SINGLE CENTER EXPERIENCE.

EHA Library, Miriam Neaman, 294490

ADDITION OF ANTI-CD33 MONOCLONAL ANTIBODY GEMTUZUMAB OZOGAMICIN TO FLAI INDUCTION SIGNIFICANTLY IMPROVES OUTCOME IN PATIENT AFFECTED BY FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Paola Minetto, 294491

A NOVEL MACHINE LEARNING DERIVED GENOMICS-BASED SCORING SYSTEM IS HIGHLY PREDICTIVE OF OUTCOME IN ACUTE MYELOID LEUKEMIA WITH RUNX1-RUNX1T1

EHA Library, Anam Shaikh, 294492

VENETOCLAX-BASED COMBINATIONS AS TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIAS AND HIGH-RISK MYELODYSPLASTIC SYNDROMES: A FRENCH EXPERIENCE

EHA Library, Tony Huynh, 294493

A PHASE-IB/II CLINICAL EVALUATION OF PONATINIB IN COMBINATION WITH AZACITIDINE IN FLT3-ITD POSITIVE ACUTE MYELOID LEUKAEMIA (ALLG AML M21)

EHA Library, David Kipp, 294494

IVOSIDENIB (IVO) PRIOR TO HEMATOPOIETIC CELL TRANSPLANT FOR PATIENTS WITH IDH1-MUTANT RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

EHA Library, Courtney D DiNardo, 294495

CDX REPORT PROGRAM - ASSESSMENT OF 311 CLINICAL REPORTS FROM 8 COUNTRIES TO ESTABLISH A REAL-WORD DATA SET OF THE CURRENT REPORTING PRACTICE FOR ONCO-HEMATOLOGY COMPANION DIAGNOSTICS (CDX) MARKERS

EHA Library, Sabit Delic, 294496

UPDATED ANALYSES OF A PHASE 1B/2 STUDY OF ONVANSERTIB, A PLK1 INHIBITOR, IN COMBINATION WITH DECITABINE IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Amer Zeidan, 294497

IADADEMSTAT SHOWS EFFICACY IN COMBINATION WITH AZACITIDINE IN ELDERLY AML PATIENTS: ALICE TRIAL

EHA Library, Olga Salamero, 294498

GLASDEGIB PLUS AZACITIDINE IN PATIENTS WITH UNTREATED HIGHER-RISK MYELODYSPLASTIC SYNDROMES, ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA: MARROW RECOVERY AND TRANSFUSION INDEPENDENCE

EHA Library, Amer Zeidan, 294499

UPDATE ON PRELIMINARY RESULTS FROM PHASE 1 FIRST-IN-HUMAN DOSE ESCALATION STUDY OF AMG 330 IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

EHA Library, Farhad Ravandi, 294500

CHARACTERISTICS AND TREATMENT STRATEGIES OF SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS: DATA FROM THE PETHEMA AML EPIDEMIOLOGIC REGISTRY

EHA Library, David Martinez-Cuadron, 294501

CLEARANCE OF PHENOTYPICALLY DISTINCT FLT3-ITD AND FLT3-TKD CLONES BY TREATMENT WITH CRENOLANIB AND CHEMOTHERAPY AS DETECTED BY LONGITUDINAL SINGLE-CELL DNA SEQUENCING ANALYSIS

EHA Library, Boo Messahel, 294502

CLINICAL AND RADIOLOGIC RESOLUTION OF INFECTIONS DURING TREATMENT WITH MBIL-21-EXPANDED CD56BRIGHT/CD16BRIGHT NK CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

EHA Library, Lucia Silla, 294503

CHEMOTHERAPY-FREE STRATEGY OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE FOR ALL-RISK ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Huaiyu Wang, 294504

RISK STRATIFICATION OF CYTOGENTICALLY-NORMAL ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA MUTATIONS BASED ON NOMOGRAM MODEL

EHA Library, Li-Xin Wu, 294505

DATA FROM FRENCH NAMED PATIENT PROGRAM OF QUIZARTINIB IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Sarah Bertoli, 294506

FIRST-IN-HUMAN STUDY OF A TRAIL RECEPTOR AGONIST FUSION PROTEIN, EFTOZANERMIN ALFA, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Mojca Jongen-Lavrencic, 294507

VENETOCLAX IN COMBINATION WITH LOW DOSE CYTARABINE, ACTINOMYCIN D AND DONOR LYMPHOCYTE INFUSIONS FOR EARLY RELAPSE OF ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Andrius Žučenka, 294508

PROGNOSTIC IMPACT OF DNA METHYLATION MODIFIER MUTATIONS ALLELIC RATIO IN FLT3-ITD ALLELIC RATIO STATUS OF ACUTE MYELOID LEUKEMIA.

EHA Library, Satoshi Wakita, 294509

TRENDS IN FIRST-LINE THERAPY CHOICE IN PATIENTS ≥ 65 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA BETWEEN 2011 AND 2018: RESULTS FROM THE AMLCG REGISTRY

EHA Library, Andreas Rank, 294510

LONG TERM DATA DEMONSTRATING INFERIOR SURVIVAL OUTCOMES IN PATIENTS WITH MYELOID SARCOMA

EHA Library, Claire Andrews, 294511

RISK-ADAPTED THERAPY BASED ON ARSENIC TRIOXIDE AND ATRA IN DE NOVO AND RELAPSED APL PATIENTS.

EHA Library, Vera Troitskaya, 294512

SAFETY AND EFFICACY OF MUTANT IDH1 INHIBITOR BAY1436032 IN SUBJECTS WITH IDH1-MUTATED AML

EHA Library, Michael Heuser, 294513

PRE-CONDITIONING INTERVENTION IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA WHO UNDERWENT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: A KSGCT MULTICENTER ANALYSIS

EHA Library, Takayoshi Tachibana, 294515

RESULTS FROM A PHASE 1 DOSE-FINDING STUDY OF CC-90009, A CEREBLON E3 LIGASE MODULATOR AND FIRST-IN-CLASS GSPT1 DEGRADER, IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (RR AML)

EHA Library, Amer M. Zeidan, 294516

TREATMENT OF AML WITH T(8;21) AND KIT MUTATIONS OR FLT3-ITD USING CHEMOTHERAPY PLUS MIDOSTAURIN: RESULTS OF THE MIDOKIT TRIAL

EHA Library, Christoph Röllig, 294517

REAL-WORLD DATA (RWD) COHORT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN THE UNITED STATES FROM AN ELECTRONIC HEALTH RECORD (EHR)–DERIVED DE-IDENTIFIED DATABASE

EHA Library, Evelyn Flahavan, 294518

REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND CLINICAL OUTCOMES FROM THE HUMANS STUDY IN MULTIPLE MYELOMA IN DENMARK, SWEDEN, AND FINLAND

EHA Library, Niels Abildgaard, 294519

VENETOCLAX ADDED TO CLADRIBINE, IDARUBICIN, AND CYTARABINE WITH OR WITHOUT A FLT3 INHIBITOR IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Tapan Kadia, 294520

MOLECULAR MINIMAL RESIDUAL DISEASE MONITORING IN NPM1-MUTATED ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE.

EHA Library, Laura Cesini, 294521

RESULTS OF THE DOSE ESCALATION PART OF DIAMOND TRIAL (CLI24-001): FIRST IN HUMAN STUDY OF SEL24/MEN1703, A DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Scott Solomon, 294522

ANALYSIS OF TREATMENTS AND OUTCOMES FOR PATIENTS WITH DE NOVO AML, THERAPY-RELATED AML AND SECONDARY AML (PRIOR MDS AND CMML) DIAGNOSED IN ENGLAND BETWEEN 2011–2016 USING HOSPITAL EPISODE STATISTICS©

EHA Library, Alex Legg, 294523

TEMPORAL TRENDS IN PRIMARY THERAPY AND RELATIVE SURVIVAL IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2017

EHA Library, Avinash Dinmohamed, 294524

CPX-351 IS WELL TOLERATED, INDUCES A HIGH COMPLETE REMISSION RATE AND FACILITATES TRANSPLANT CONSOLIDATION IN POOR RISK ACUTE MYELOID LEUKEMIA PATIENTS: RESULTS FROM ITALIAN COMPASSIONATE USE PROGRAM

EHA Library, Fabio Guolo, 294525

ALDEHYDE DEHYDROGENASE GENETIC VARIANTS INFLUENCE THE RISK MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA DEVELOPMENT AND PROGRESSION

EHA Library, Ana Bela Sarmento-Ribeiro, 294526

SAFETY RUN-IN COHORT 1 OF GIMEMA AML1718: A SAFETY RUN-IN AND PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, CYRATABINE AND IDARUBICINE (V-FLAI) IN INDUCTION THERAPY OF ACUTE MYELOID LEUKEMIA

EHA Library, Giovanni Marconi, 294527

THE WHO 2016 DIAGNOSTIC CRITERIA FOR ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES (AML-MRC) ARTIFICIALLY PRODUCE A HETEROGENOUS ENTITY

EHA Library, Julia Peters, 294528

INCIDENCE AND OUTCOME OF PATIENTS WITH RARE ACUTE PROMYELOCYTIC LEUKEMIA VARIANTS: THE PETHEMA-APL REGISTRY EXPERIENCE.

EHA Library, Marta Sobas, 294529

FINANCIAL IMPLICATIONS OF EARLY HOSPITAL DISCHARGE FOLLOWING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS 2014-2018

EHA Library, Roland B. Walter, 294530

THE PRESENCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES IN PATIENTS AFFECTED BY ACUTE MYELOID LEUKEMIA WITH INV(16)(P13.1Q22) OR T(16;16)(P13.1;Q22);): MULTICENTRIC EXPERIENCE.

EHA Library, Silvia Imbergamo, 294531

RECOMBINANT THROMBOMODULIN REDUCES THE RISK OF DIFFERENTIATION SYNDROME AND ATRA RELATED SEVERE ADVERSE EVENTS DURING INDUCTION CHEMOTHERAPY FOR APL.

EHA Library, Norifumi Sugawara, 294532

FLUDARABINE, HIGH DOSE CYTARABINE AND IDARUBICIN-BASED INDUCTION OVERCOMES THE NEGATIVE PROGNOSTIC IMPACT OF FLT3-ITD MUTATION IN NPM1-MUTATED AML IRRESPECTIVELY OF FLT3-ITD ALLELIC BURDEN

EHA Library, Paola Minetto, 294533

CONDITIONAL RELATIVE SURVIVAL IN ADULT PATIENTS DIAGNOSED WITH ACUTE PROMYELOCYTIC LEUKEMIA IN THE NETHERLANDS: A POPULATION-BASED STUDY, 1989-2017

EHA Library, Avinash Dinmohamed, 294534

RISK FACTORS AND CLINICAL OUTCOMES OF AML PATIENTS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

EHA Library, Georgina Stefania Daher, 294535

KINETICS OF BONE MARROW BLASTS AND USEFULNESS OF DAY 14 AND DAY 21 ASSESSMENT DURING INDUCTION OF ACUTE MYELOID LEUKEMIA

EHA Library, Zdenek Racil, 294536

GEMTUZUMAB OZOGAMICIN COMBINED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS RELAPSING AFTER ALLOGENIC STEM-CELL TRANSPLANTATION

EHA Library, Alexis Genthon, 294537

PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF IVOSIDENIB OR ENASIDENIB COMBINED WITH INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED IDH1/2-MUTANT AML

EHA Library, Yue Chen, 294538

HIGH RATE OF DURABLE REMISSIONS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CORE-BINDING FACTOR ACUTE MYELOID LEUKAEMIA IN SECOND COMPLETE REMISSION

EHA Library, Matthew James Rees, 294539

MOLECULAR/DIAGNOSTIC TESTING PATTERNS IN ELDERLY PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) IN THE CONNECT® MDS/AML DISEASE REGISTRY

EHA Library, Tracy George, 294540

INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA TREATED WITH FLAI (FLUDARABINE, IDARUBICIN, CYTARABINE) INDUCTION: ANALYSIS OF FACTORS AFFECTING SURVIVAL AND EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Davide Lazzarotto, 294541

CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA IS AN INDEPENDENT MARKER OF POOR PROGNOSIS IN INTENSIVELY-TREATED PATIENTS

EHA Library, Joana Infante, 294542

IMPROVING OUTCOMES AND VALUE FOR PATIENTS OVER 60 WITH SECONDARY ACUTE MYELOID LEUKEMIA (S-AML) THROUGH INDUCTION WITH HIGH-DOSE MITOXANTRONE AND CYTARABINE (5+1)

EHA Library, Matthew Ulrickson, 294543

THE COMPARATIVE EFFECTIVENESS OF GLASDEGIB COMBINED WITH LOW-DOSE CYTARABINE VERSUS AZACITIDINE AMONG NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS WHO ARE INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Sophie Van Beekhuizen, 294544

INTEGRATIVE STUDY OF EZH2 MUTATIONAL STATUS, COPY NUMBER, PROTEIN EXPRESSION AND H3K27 TRIMETHYLATION IN AML/MDS PATIENTS

EHA Library, Julia Stomper, 294545

IDENTIFICATION OF PML-RARA, CBFB-MYH11 AND RUNX1-RUNX1T1 GENOMIC FUSION SEQUENCES IS FEASIBLE AND ENABLES UNAMBIGUOUSLY INTERPRETABLE AND SENSITIVE MONITORING OF MINIMAL RESIDUAL DISEASE

EHA Library, Julius Lukes Jr., 294546

EVALUATING THE ROLE OF FLUORESCENCE IN SITU HYBRIDIZATION AS A SINGLE PROGNOSTIC MODALITY IN ACUTE MYELOID LEUKEMIA

EHA Library, Gal Sharvit, 294548

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN UNFIT PATIENTS WITH AML RECEIVING FIRST LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (CURRENT): AN INTERIM ANALYSIS

EHA Library, Je-Hwan Lee, 294549

THERAPY-RELATED MYELOID NEOPLASMS CAN BE PREDICTED USING ROUTINE LABORATORY VALUES AND WITHOUT BONE MARROW BIOPSIES IN PATIENTS WITH CYTOPENIAS AFTER TREATMENT FOR BREAST CANCER

EHA Library, Giulia Petrone, 294550

EFFECT OF EARLY BLOOD COUNTS ON RESPONSE AND OVERALL SURVIVAL FOLLOWING GLASDEGIB PLUS LDAC IN NEWLY DIAGNOSED AML: BRIGHT AML 1003 POST HOC ANALYSIS.

EHA Library, Eunice Wang, 294551

CHARACTERIZATION OF CLINICAL PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS OF AMG 330, A BISPECIFIC CD33 T-CELL ENGAGER ANTIBODY CONSTRUCT, IN PATIENTS WITH RELAPSED/REFRACTORY AML

EHA Library, Suresh Agarwal, 294552

IS LESS MORE IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA? THE IMPACT OF THE INTRODUCTION OF CLINICAL TRIALS AT OUR INSTITUTION

EHA Library, Angel Serna, 294553

A FIRST IN HUMAN STUDY OF SEL120, A NOVEL ORAL SELECTIVE CDK8/19 INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Małgorzata Borowiak, 294554

MIDOSTAURIN IN COMBINATION WITH INTENSIVE CHEMOTHERAPY IN PATIENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML). A 'REAL LIFE' MULTI-CENTER EXPERIENCE FROM SPANISH TERTIARY HOSPITALS.

EHA Library, Mar Tormo, 294555

REAL-WORLD TOLERABILITY OF VENETOCLAX-BASED THERAPY IN COMBINATION WITH AZOLE ANTIFUNGAL THERAPY FOR ACUTE MYELOID LEUKAEMIA IN REMISSION

EHA Library, Ing Tiong, 294556

RESULTS OF A PILOT STUDY COMBINING CRENOLANIB WITH STANDARD SALVAGE CHEMOTHERAPY IN RELAPSED/REFRACTORY AML

EHA Library, Robert Collins, 294557

A EFFECTIVE TOOL FOR GERIATRIC ASSESSMENT IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: A MULTICENTER STUDY FROM CHINA

EHA Library, Chun-Li Zhang, 294558

A MODIFIED IA REGIMEN LEADS TO DECREASED MRD LEVELS AND A SURVIVAL ADVANTAGE FOR AML PATIENTS TRANSFORMED FROM MDS

EHA Library, Xueying Li, 294559

LOW-DOSE VENETOCLAX IS EFFECTIVE AND FREQUENTLY USED IN ADULTS WITH ACUTE MYELOID LEUKEMIA. A STUDY OF THE ACUTE LEUKEMIA WORKING GROUP (GTLA).

EHA Library, Andrés Gomez De León, 294560

GEMTUZUMAB OZOGAMICIN PLUS STANDARD CHEMOTHERAPY CARRIES A COMPARABLE BURDEN OF HOSPITALIZATION COMPARED WITH STANDARD CHEMOTHERAPY ALONE IN ACUTE MYELOID LEUKEMIA

EHA Library, Slaven Sikirica, 294561

SYNERGISTIC ANTI-LEUKEMIA EFFECT OF AZACITIDINE PLUS HOMOHARRINGTONINE AND THERAPEUTIC RESPONSE OF THE NOVEL COMBINATION-BASED REGIMENS IN ACUTE MYELOID LEUKEMIA WITH UNFAVORABLE OUTCOME

EHA Library, Zheng Ge, 294562

IMPACT OF LEUKOCYTAPHERESIS AND OTHER PARAMETERS ON EARLY 30-DAY MORTALITY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PRESENTING WITH HYPERLEUKOCYTOSIS AND/OR LEUKOSTASIS

EHA Library, A. Emre Eskazan, 294563

PROGNOSTIC RELEVANCE OF THE DIFFERENT PML-RARA VARIANT TRANSCRIPTS AND FLT3-ITD STATUS IN ADULTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Gueorgui Balatzenko, 294564

TUMOR LYSIS SYNDROME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX-CONTAINING REGIMENS

EHA Library, Rabia Shahswar, 294565

A NOVEL ONE STEP NGS ASSAY FOR ACCURATE DIAGNOSIS AND ULTRASENSITIVE MONITORING FOR DETECTION OF FLT3-ITD IN AML PATIENTS

EHA Library, Rakhi Salve, 294566

IMPACT OF BONE MARROW TREGS ON RESPONSE RATE AND SURVIVAL OF YOUNGER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Mario Delia, 294567

THROMBOSIS IN ACUTE MYELOID LEUKEMIA – WHO ARE THE HIGH RISK PATIENTS?

EHA Library, Mirjana Mitrovic, 294568

IMPACT OF SMALL EXTRACELLULAR VESICLES IN CHRONIC LYMPHOCYTIC LEUKAEMIA MICROENVIRONMENT

EHA Library, Ernesto Gargiulo, 294569

CD49D/CD29 CONTRIBUTES TO MURINE MARGINAL ZONE B CELL DEVELOPMENT IN SPLEEN AND TO LEUKEMIC INFILTRATION OF TCL1 TRANSGENIC MICE

EHA Library, Tanja Nicole Hartmann, 294570

COMBINATION OF EPIGENETIC DRUG SCREEN AND CRISPR KNOCKOUT SCREEN REVEALED INVOLVEMENT OF AURORA KINASES AND CULLIN 3 IN CD20 REGULATION

EHA Library, Aneta Ledererova, 294571

IBRUTINIB TREATMENT AFFECTS ΜRNA TRANSLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Kostas Stamatopoulos, 294572